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Objective: To determine the number of employed people in a 
group of patients with neuromuscular diseases and in 3 sepa-
rate subgroups (facioscapulo-humeral dystrophy, hereditary 
motor and sensory neuropathy, and myotonic dystrophy) to 
investigate any differences in employment status between 
the patient groups, and to identify factors related to employ-
ment status.
Design: Cross-sectional study.
Patients: A total of 591 patients with neuromuscular diseases 
participated in the study, 138 with facioscapulo-humeral 
dystrophy, 135 with hereditary motor and sensory neuro-
pathy, and 318 with myotonic dystrophy.
Methods: Self-report questionnaires, the Checklist Individu-
al Strength (CIS) and the Short Form-36 (SF-36).
Results: Of the patients with neuromuscular diseases in the 
study, 56.7% were employed. Younger age, being male, and 
higher education contributed significantly to employment 
status of the neuromuscular diseases group and the heredi-
tary motor and sensory neuropathy and myotonic dystrophy 
subgroups. Significant between-group differences for em-
ployed vs not employed subjects were present in the total 
neuromuscular diseases group on all subscales of the CIS 
and SF-36. Factors related to employment status differed for 
the 3 neuromuscular diseases subgroups.
Conclusion: More than half of the patients with neuromus-
cular diseases were employed. Patients with facioscapulo-
humeral dystrophy and patients with hereditary motor and 
sensory neuropathy were more often employed than patients 
with myotonic dystrophy. Between-group analyses for dif-
ferences in baseline factors revealed 11 significant factors re-
lated to employment. Multivariate logistic analyses revealed 
6 factors contributing to employment for the group of pa-
tients with neuromuscular diseases. 
Key words: employment; neuromuscular disease; CIS; SF-36; 
rehabilitation.
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INTRODUCTION
Employment is recognized worldwide as important to all 
people, including those with disabilities and chronic diseases. 
People in gainful employment, again including those with 
chronic diseases, enjoy greater health, wellbeing, and sense 
of fulfilment in their lives (1–8). Healthcare professionals, 
politicians, and patient organizations all recognize the value 
of empowering people with a disability by way of gainful 
employment.
Three moderately prevalent progressive neuromuscular dis-
eases (NMD) were chosen for this study based on their onset 
at working age with a progressive impact on performing daily 
activities that is also likely to affect gainful employment (9, 
10). Facioscapulo-humeral dystrophy (FSHD) is a genetic mus-
cular dystrophy. Hereditary motor and sensory neuropathy type 
I (HMSN) is a genetic peripheral nerve disease. Adult-onset 
myotonic dystrophy (MD) is a genetic multi-organ disorder 
also affecting cognitive function. A systematic review revealed 
10 factors associated with employment status: disorder-related 
factors, factors related to functions, general personal factors, 
and work-related personal factors (11). This study is a second-
ary analysis of data from the study by Kalkman et al. (10). We 
selected from this study those measurement instruments that 
were likely to impact on employment status.
This analysis seeks to answer the following research ques-
tions: (i) How many NMD patients of working age are gainfully 
employed and what are their characteristics? (ii) Are there 
differences in employment status among the 3 subgroups of 
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patients with FSHD, HMSN, and MD? (iii) Which disease-
related, personal, fatigue severity, and functional health status 
factors, are related to employment of the NMD patient group 
and the 3 patient subgroups?
METHODS
Subjects 
In their cross-sectional study Kalkman et al. (10) contacted patients with 
a definitive medical diagnosis of NMD using patient databases from the 
Neuromuscular Centre Nijmegen and the Dutch Neuromuscular Patient 
Association (Vereniging Spierziekten Nederland). With a response rate 
of 72%, these researchers were able to recruit 598 patients with FSHD, 
HMSN and MD aged 18–68 years. The study was approved by the local 
ethics committee and all subjects signed an informed consent. The sample 
was described in terms of general personal factors, participation in volun-
teer work, fatigue, functional health status, and employment status. For 
this secondary analysis examining employment status, one patient was 
excluded for being over the retirement age of 65 years, and 6 patients were 
excluded due to incomplete or missing data with regard to employment 
status. Thus, 591 patients were included in this secondary analysis: 138 
patients with FSHD, 135 with HMSN, and 318 with MD.
Measurement instruments
For this analysis those data from measurement instruments used in the 
primary study (10) that were likely to be associated with employment 
status were selected. These included data from a patient questionnaire, 
the Checklist Individual Strength (CIS), and 4 subscales of the Short 
Form-36 (SF-36) functional health status measure. 
Patient questionnaire 
For the original study, employment was defined as the state of being 
engaged in an activity or service for salary (gainful employment). 
In the questionnaire used by Kalkman et al. (10) 5 categories of 
employment status were defined: 0–8, 9–16, 17–24, 25–32 or > 32 h/
week. Although this cut-off value does not correspond to the Dutch 
governmental recognition of economic importance of working ≥ 12 h/
week (12), for this secondary analysis the data available on employ-
ment status were dichotomized into either employed (working ≥ 9 h/
week) or not employed (working 0–8 h/week).
Marital status was dichotomized as single or domestic union/mar-
ried. Participation in volunteer work was dichotomized into perform-
ing volunteer work or not, because no data on the number of hours 
of voluntary work was included in the primary study. Data collected 
on highest educational level attained consisted of 3 categories: lower 
educated (primary school), intermediate educated (secondary school), 
and higher educated (post-secondary level).
Checklist Individual Strength
The CIS is a multidimensional instrument with 4 subscales (fatigue 
severity, concentration problems, reduced motivation, and reduced 
activity) to measure the level and impact of fatigue in patients with 
chronic diseases and in healthy people (13–15). Each subscale item 
can be scored on a 7-point Likert scale. A higher composite subscale 
score indicates higher levels of fatigue, higher levels of concentration 
problems, lower motivation, and lower levels of activity (13). Although 
in the literature the fatigue scale has been dichotomized, with a score 
≥ 35 used to identify severe fatigue (10, 14), all subscale scores were 
analysed here as ratio-level data. The total CIS score has demonstrated 
good reliability and validity (16, 17).
Functional health status
The Medical Outcomes Study Short Form General Health Survey (SF-
36) uses 36 questions to measure 8 aspects of functional health status 
(18). Item scores are added and transformed to a 100-point scale to 
produce subscale scores. Higher scores indicate better health status. 
For this secondary analysis 4 subscales were used that were thought 
to be relevant to employment status: physical functioning (10 items), 
social functioning (2 items), vitality (4 items), and bodily pain (2 items) 
The SF-36 has been shown to have adequate reliability and validity, 
both for total and subscale scores (18).
Data analysis
Descriptive statistics are presented separately for all variables of 
employed and not employed NMD patients. These descriptive data 
were analysed for between-group differences with univariate analyses 
(ANOVA) for numeric and continuous variables and χ2 analyses for 
ordinal variables both for the total NMD group (Table I) and for the 3 
subgroups (Table II). We regarded p < 0.05 as statistically significant.
Further statistical analyses were performed for the total NMD group 
and for the 3 subgroups with employment status as the dependent 
variable. Stepwise forward multivariate logistic regression analyses 
using SPSS software (Version 15.0 for Windows®) were performed 
to examine the contribution of the variables to employment status for 
the total NMD group and for the 3 patient subgroups, allowing us to 
present odds ratios and calculate variance (Table III). In the stepwise 
procedure we used p < 0.15 for inclusion and p > 0.05 for exclusion 
of variables in the model. 
Table I. Personal factors, level of fatigue, and health status of the total 
with patient group neuromuscular diseases (NMD) employed and not 
employed (n = 591)
Variable Employed†
Not 
employed† p-value* 
Total, % (n) 56.7 (335) 43.3 (256)
Age mean (SD)
Gender, % (n)
Men
Women
40.4 (9.96)
52.8 (177)
47.2 (158)
46.1 (9.52)
35.2 (90)
64.8 (166)
< 0.001
< 0.001
Marital status, % (n)
Single
Living together/married
31 (104)
69 (231)
27.1 (69)
72.9 (187)
0.291
Education level, % (n)
Lower
Intermediate
Higher
18.8 (63)
50.7 (170)
30.4 (102)
40.8(104)
47.8 (122)
11.4 (29)
< 0.001
Volunteer, % (n)
Yes
No
23.5 (78)
76.5 (254)
19.6 (50)
80.4 (205)
0.269
CIS, mean (SD)
CIS fatigue (8–56) 
CIS concentration (5–35) 
CIS motivation (4–28)
CIS activity (3–21)
36.5 (12.17)
13.4 (7.72)
13.2 (6.35)
9.8 (5.32) 
41.7 (11.44)
17.3 (9.04)
16.5 (6.76)
13.9 (5.57)
< 0.001
< 0.001
< 0.001
< 0.001
SF-36 Health Status‡, mean (SD) 
Physical functioning (0–100)
Social functioning (0–100)
Vitality (0–100)
Bodily pain (0–100)
52.5 (27.63)
72.4 (22.65)
49.0 (19.22)
74.0 (23.73)
43.8 (29.08) 
66.8 (25.74)
45.2 (19.82)
69.9 (26.02)
< 0.001
0.006
0.017
0.046
Differences in proportions tested with χ2; group means tested by analysis 
of variance (ANOVA). 
*A p-value < 0.05 was regarded as statistically significant.
†Employed defined as working ≥ 9 h/week; not employed defined as 
working < 9 h/week.
‡SF-36. A higher value indicates a better health status on a scale of 
0–100. 
CIS: Checklist Individual Strength; SF-36: 36-item Short Form health 
survey; SD: standard deviation.
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RESULTS
Data on personal factors, level and impact of fatigue, and 
functional health status for the total NMD group of employed, 
and not employed NMD patients are presented in Table I. The 
results for the 3 subgroups are presented in Table II. In Table 
III the contribution of different factors to employment status 
is presented for the total NMD group and the subgroups.
Between-group analysis
Employment status. In the total NMD group, 56.7% of patients 
were gainfully employed. Employment status differed signifi-
cantly from this percentage for the total group for both the 
FSHD (70.3% employed; p < 0.001) and the HMSN (63.7%; 
p = 0.001) subgroups, but not the MD subgroup (47.8%; 
p = 0.432) (Table I and II).
Gender and age. Between-group analysis showed significant 
differences with regard to gender and age: NMD patients who 
were employed were younger and more often male than the 
not employed patients (Table I). In all 3 subgroups, younger 
patients were employed to a significantly greater degree than 
older patients. For the FSHD and MD subgroups, the correla-
tion between being male and being gainfully employed was 
also significant (Table II).
Participation in volunteer work. The employed NMD patients 
did not perform significantly more volunteer work than not 
employed patients (Table I and II).
Marital status. No significant differences were found for mari-
tal status for the total NMD group or for the 3 subgroups be-
tween employed and not employed patients (Table I and II). 
Educational level. Significant between-group differences were 
noted in the level of education for the total NMD patient group. 
Employed NMD patients were, on average, significantly higher 
educated than not employed patients. Of the employed NMD 
patients, 30.4% had higher, 50.7% intermediate, and 18.8% 
lower education. For the not employed patients these percent-
ages were 11.4%, 47.8%, and 40.8%, respectively (Table I). 
Of the employed patients, 81.1% had higher or intermediate 
educational background vs 59.2% in the non-employed group 
(Table I). Signi ficant between-group differences with regard 
Table II. Personal factors, level of fatigue and health status of patients with facioscapulo-humeral dystrophy (FSHD), hereditary motor and sensory 
neuropathy (HMSN) and myotonic dystropy (MD) employed and not employed
Variable
FSHD 
n = 138
HMSN 
n = 135
MD 
n = 318
Employed†
Not 
employed† p-value* Employed†
Not 
employed† p-value* Employed†
Not 
employed† p-value*
Total, % (n) 
Total, 95% CI
70.3 (97) 
39.98–44.03
29.7 (41)
44.61–50.46
< 0.001 63.7 (86)
38.27–42.70
36.3 (49)
42.61–48.58
0.001 47.8 (152)
37.84–40.95
52.2 (166)
44.55–47.43
0.432
Mean age (SD)
Gender, % (n)
Men 
Women
42 (10.05)
55.7 (54) 
44.3 (43) 
47.5 (9.26)
31.7 (13)
68.3 (28)
0.003
0.010
40.5 (10.33)
43 (37)
57 (49)
45.6 (10.38)
32.7 (16)
67.3 (33)
0.007
0.235
39.4 (9.61)
56.6 (86)
43.4 (66)
45.9 (9.35)
36.7 (61)
63.3 (105)
< 0.000
< 0.000
Marital status, % (n)
Single
Living together/married
24.7 (24) 
75.3 (73) 
26.8 (11)
73.2 (30)
0.797 32.6 (28)
67.4 (58)
30.6 (15)
69.4 (34)
0.815 34.2 (52)
65.8 (100)
26.1 (43)
73.9 (122)
0.114
Education level, % (n)
Lower 
Intermediate
Higher
14.4 (14)
48.5 (47)
34.1 (36)
31.7 (13)
56.1 (23)
12.2 (5)
0.005 11.6 (10)
50.0 (43)
38.4 (33)
18.4 (9)
55.1 (27)
26.5 (13)
0.294 25.7 (39)
52.6 (80)
21.7 (33)
49.7 (82)
43.6 (72)
6.7 (11)
< 0.000
Volunteer work, % (n)
Yes
No
33.0 (32)
67.0 (65)
26.8 (11)
73.2 (30)
0.475 26.7 (23)
73.3 (63)
31.3 (15)
68.8 (33)
0.579 15.4 (23)
84.6 (126)
14.5 (24)
85.5 (142)
0.808
CIS mean (SD)
CIS fatigue (8–56) 
CIS concentration (5–35) 
CIS motivation (4–28)
CIS activity (3–21)
34.8 (12.10)
11.6 (6.99)
11.8 (5.50)
8.9 (4.77)
41.4 (10.90)
14.1 (10.29)
13.0 (6.54)
13.0 (5.80)
0.003
0.105
0.257
< 0.001
37.0 (12.33)
13.0 (8.28)
11.9 (5.84)
9.1 (5.58)
36.8 (13.08)
15.2 (9.27)
12.7 (6.45)
9.9 (5.35)
0.929
0.169
0.459
0.450
37.3 (12.10)
14.7 (7.65)
14.9 (6.75)
10.8 (5.37)
43.2 (10.70)
18.6 (8.36)
18.4 (6.07)
15.3 (4.96)
< 0.000
< 0.000
< 0.000
< 0.000
SF-36 Health Status‡, mean (SD) 
Physical functioning (0–100)
Social functioning (0–100)
Vitality (0–100)
Bodily pain (0–100) 
52.2 (30.67)
74.1 (22.55)
55.5 (17.56)
71.3 (22.83)
29.0 (26.41)
67.9 (25.47)
48.3 (19.15)
57.9 (20.65)
< 0.001
0.164
0.033
0.002
53.8 (24.67)
68.7 (24.61)
49.6 (20.45)
72.7 (22.85)
53.9 (28.53)
66.2 (23.73)
50.7 (19.36)
61.6 (28.31)
0.974
0.568
0.752
0.015
52.0 (27.33)
73.3 (21.46)
44.6 (18.42)
76.4 (24.67)
44.6 (28.58)
66.7 (26.49)
42.8 (19.81)
75.1 (25.07)
0.019
0.015
0.393
0.646
Differences in proportions tested with χ2; group means tested by analysis of variance (ANOVA).
*A p-value < 0.05 was regarded as statistically significant.
†Employed defined as working ≥ 9 h/week; not employed defined as working < 9 h/week.
‡SF-36. A higher value indicates a better health status on a scale of 0–100. 
CI: confidence interval; CIS: Checklist Individual Strength; SF-36: 36-item Short Form Health Survey; SD: standard deviation.
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to educational level were also noted in the FSHD and MD 
subgroups (Table II).
Checklist Individual Strength. Significant between-group dif-
ferences for the 4 subscales of the CIS were present in the total 
NMD group. Employed NMD patients reported significantly 
less fatigue, fewer concentration problems, better motivation, 
and higher levels of activity than the not employed NMD 
group (see Table I). Of note was that both employed and not 
employed NMD patients reported severe fatigue (cut-off ≥ 35 
on the CIS fatigue subscale) (Table I). Despite this CIS fatigue 
score (mean 36.5, SD 12.1) a high percentage of NMD patients 
were still gainfully employed. 
Subgroup analysis also showed significant between-group 
differences in the FSHD and MD subgroups with regard to fa-
tigue severity level. Employed FSHD and MD patients reported 
significantly less fatigue compared with not employed patients. 
The fatigue score for the employed FSHD group (mean 34.8, 
SD 12.1) was below the cut-off for severe fatigue (Table II). The 
employed FSHD and MD patient group also reported significantly 
higher levels of activity. The employed MD patient group reported 
significantly fewer concentration problems and better motivation 
(Table II). No significant between-group differences were present 
for the HMSN subgroups for the 4 CIS subscales (Table II).
Functional health status. For the total NMD group between-
group analysis showed significant differences in health status. 
The employed NMD patient group had a significantly higher 
score on the SF-36 subscales physical functioning, social func-
tioning, vitality, and bodily pain compared with the not employed 
patient group, indicating a better health status (Table I).
Subgroup analysis showed more varied between-group dif-
ferences. The employed FSHD group reported significantly 
better physical functioning, more vitality, and less bodily pain 
than the not employed FSHD group. The employed HMSN 
group reported significantly less bodily pain. The employed 
MD group reported significantly better physical and social 
functioning (Table II).
Multivariate analysis
Total neuromuscular diseases group. All of the factors that 
were found to contribute significantly to employment status 
from the multivariate logistic regression for the total NMD 
group are shown in Table III, presented as odds ratios (OR). 
Factors that contributed significantly to employment status for 
the total NMD patient group were age, gender, and educational 
level, CIS concentration score, CIS activity score, and SF-36 
physical functioning score. Together these factors explained 
37.2% of variance with regard to employment status.
For the total NMD group the odds of being employed de-
creased 6% for each year with increasing age, controlling for 
other variables in the model. The odds for a male being employed 
were 3 times higher than for a woman, and higher educated 
NMD patients had 5.6 higher odds of being employed than 
lower educated NMD patients (Table III). The odds of being 
Table III. Logistic regression analyses to predict employment status in the total neuromuscular diseases (NMD) group and for the 3 patient groups: 
facioscapulo-humeral-dystrophy (FSHD), hereditary-motor- and-sensory-neuropathy (HMSN) and myotonic-dystrophy (MD)
Independent variables
Dependent variable employment
NMD
n = 591 (256/335)*
FSHD
n = 138 (41/97)*
HMSN
n = 135 (49/86)*
MD
n = 318 (166/152)*
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Age 0.94 (0.92–0.96) < 0.001 0.94 (0.89–0.98) 0.001 0.97 (0.89–0.96) < 0.001
Gender (male) 0.33 (0.22–0.49) < 0.001 0.22 (0.085–0.605) 0.003 0.28 (0.161–0.508) < 0.001
Marital status
Education
Lower 1 < 0.001 1 0.015 1 < 0.001
Intermediate 1.9 (1.21–3.01) <0.001 1.2 (0.41–3.66) 0.008 2.2 (1.25–4.13) < 0.001
Higher 5.6 (3.12–10.37) 0.005 6.6 (1.64–26.69) 0.708 9.9 (3.93–25.19) 0.007
Volunteer 
Voluntary work
CIS
CIS fatigue
CIS concentration 0.97 (0.95–0.99) 0.026 0.95 (0.91–0.99) 0.023
CIS motivation
CIS activity 0.89 (0.86–0.93) < 0.001 0.86 (0.79–0.94) 0.001 0.86 (0.81–0.91) < 0.001
SF-36 Health Status
Physical functioning 1.072 (> 1.000–1.149) 0.050 1.233 (1.047–1.452) 0.012
Social functioning 
Vitality
Bodily pain 1.26 (1.077–1.490) 0.004
Nagelkerke R2 0.372 0.397 0.206 0.424
* Not employed (0–8 h)/Employed (9–40 h).
R2 is the percentage of variance of the dependent variable score, explained by the independent variables together. 
Relationship between patient factors with the dependent variable employment (p < 0.05).
Only significant odds ratios (OR) with accompanying 95% confidence interval (95% CI).
CIS: Checklist Individual Strength; SF-36: 36-item Short Form Health Survey.
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employed increased 3% with each higher level of CIS concen-
tration (expressed in a lower score OR 0.97) and the odds of 
being employed increased 11% with each higher level of CIS 
activity (expressed in a lower score OR 0.89). The odds of being 
employed increased 0.72% with each unit increase of the score 
on the subscale SF-36 physical functioning (Table III). 
Subgroups. Similar analyses were performed to predict em-
ployment status for all 3 subgroups. For the FSHD group, male 
patients with a higher education, higher CIS activity score, and 
better SF-36 physical functioning score were more likely to be 
employed: 39.7% of the variance was explained by these factors 
(Table III). For the HMSN group age, higher levels of concen-
tration and less pain contributed significantly to employment 
status: 20.6% of the variance was explained by these factors 
(Table III). For the patients with MD, younger males with higher 
education levels and higher CIS activity score were most likely 
to be employed: These factors explained 42.4% of the variance 
in employment status (Table III). Of note was that educational 
level was an important explanatory variable for employment in 
both the FSHD and MD subgroups (OR 6.6–9.95). 
DISCUSSION
In contrast to earlier published reports (9, 19), this study indi-
cates that a high percentage of patients with NMD are gainfully 
employed, particularly in the FSHD and HMSN subgroups. A 
lower employment percentage was confirmed only for the MD 
subgroup in this study. In addition, it was found that employed 
NMD patients are younger, more often male, and higher educated 
than the not employed NMD patients. Four factors identified in 
a systematic review of the literature on factors associated with 
employment status in patients with NMD (11) were consistent 
with the findings of this study: NMD type, age, gender, and 
educational level. This impact of age is also in agreement with 
the findings by Andries (20), who reported a more rapid decrease 
in employment status in patients with NMD increasing age. 
In our study the HMSN and patient with MD subgroups 
reported a significant relationship between age and employ-
ment status. Furthermore, being male was a relevant factor for 
the FSHD and MD subgroups. On average, the employed MD 
patients had attained a lower educational level than the other 
2 subgroups. We hypothesize that the fact that MD is a multi-
organ disorder that also affects cognitive function might explain 
this lower educational level and, related to the nature of this 
pathology, lower employment level compared with the FSHD 
and HMSN subgroups (21). Fowler et al. (9) also noted a cor-
relation between the type of NMD and educational level. They 
stated that patients with higher education were more frequently 
working in clerical positions. Clerical jobs are less physically 
strenuous than heavy manual jobs, and higher education thereby 
provides a plausible explanation for employment status.
We expected to find a lower educational level in the MD sub-
group, based on the nature of the pathology. Lower educational 
levels were expected to result in a higher percentage of these pa-
tients working in more strenuous jobs, leading to earlier disability 
pension and a lower employment rate (10, 19). In this study the 
percentage of higher educated patients with MD was found to be 
low. It was notable that the chance of being employed was almost 
10 times better for the patients with MD higher education com-
pared with those with lower education. The clinical implication of 
this finding is that special attention appears warranted to explain 
to patients with MD at an early age the importance of educational 
level and to encourage them to study, if their condition allows 
it, as education has been found to have a strong correlation with 
future opportunities in the labour market. 
The variance explaining employment status for the contribut-
ing factors identified was relatively high for the FSHD (39.7%) 
and the MD (42.4%), but more limited for the HMSN subgroup 
(20.6%). Of all the factors included in the regression analyses, 
none were relevant for all 3 subgroups. Education was shown 
to be the most important variable in the FSHD and MD sub-
group in explaining association with employment status. Age 
was an important variable for the HMSN and MD subgroups 
and gender for the FSHD and MD subgroups. 
Severe fatigue and pain are major complaints in patients with 
NMD (10, 22–28) and we expected that fatigue and pain would 
influence employment status in the NMD patient groups. The 
variability with regard to fatigue severity for type of NMD 
was large. However, despite high levels of fatigue severity, the 
levels of employment were also relatively high. This seems to 
indicate that fatigue severity may not be the reason why the 
patients in this study were not participating in the workforce. 
There was a significant between-group difference with regard 
to reported pain in the total NMD group and in the FSHD and 
HMSN subgroups. However, less pain was a contributing factor 
only with regard to employment for the HMSN subgroup. In 
the regression analyses the CIS fatigue and motivation subscale 
scores did not contribute to the calculated variance in employ-
ment status in any of the 3 subgroups. This study indicates that 
fatigue severity and motivation do not affect participation in 
the workforce for patients with MD.
A significant between-group difference was found between 
the 4 SF-36 subscales: physical functioning, social function-
ing, vitality, and bodily pain. Subscale scores were higher in 
those patients who were employed, indicating better health 
status. Regression analysis detected the subscale factor SF-36 
physical functioning as a variable that could partly explain the 
variance of employment status in the total NMD group and in 
the FSHD subgroup. We suggest that if factors could be found 
that influence employment in patients with NMD, it might be 
helpful in the development of treatment strategies for (allied) 
health professionals to assist patients with NMD to return to 
work and/or to stay employed.
Although 11 factors that influenced gainful employment 
status were found in the sample of patients with NMD studied, 
6 of which were also found to be relevant using multivariate 
logistic analyses, a maximum of only 42.4% of the variance 
was explained, which leaves 57.6% unexplained with the fac-
tors in the present model. Due to the limitations with regard 
to data selected, additional relevant predictive factors influ-
encing employment were probably not taken into account. 
Environmental factors are, for example, not encountered in 
this study and might influence employment status in NMD 
J Rehabil Med 42
65Employment status in neuromuscular diseases
patients, as was found in other cross-sectional studies (4, 9, 
12, 29–31). Other studies also recommend that determinants 
such as adequate referral patterns, goal setting, motivation, 
expectation, job seeking, work maintenance, work demands, 
terms of employment (type of job, amount of hours worked, 
ability to regulate working hours) should be addressed (9, 12, 
32, 33). Social support, facilitation, and compensation for bar-
riers to employment when disabled and chronically ill patients 
such as NMD patients attempt to return to work also need to 
be addressed in future studies (21, 33, 34). This stresses the 
importance of specific qualitative research to identify further 
modifiable variables related to employment in order to enhance 
labour participation of the patient group in our study.
ACKNOWLEDGEMENTS
The study was supported by “HBO Mobiliteitsfonds” and the HAN Uni-
versity of Applied Sciences, Nijmegen, The Netherlands.
REFERENCES
Yelin E, Henke C, Epstein W. The work dynamics of the person 1. 
with rheumatoid arthritis. Arthritis Rheum 1987; 30׃ 507–512.
Warr P. Work, unemployment and mental health. Oxford: Claren-2. 
don Press; 1987.
Verkleij HP. Onderzoek naar de gevolgen van chronische aan-3. 
doeningen voor het dagelijks functioneren: kwaliteit van leven. 
[Research into the consequences of chronic diseases in daily 
functioning: quality of life]. Tijdschr Soc Gezondheidsz 1991; 
69: 221–227 (in Dutch).
Wevers CWJ, Brouwer OF, Padberg GW, Nijboer ID. Job perspec-4. 
tives in fascioscapulohumeral muscular dystrophy. Disabil Rehabil 
1993; 15: 24–28.
Chorus AMJ, Miedema MJ, Boonen A Van Der Linden S. Qual-5. 
ity of life and work in patients with rheumatoid arthritis and 
ankylosing spondylitis of working age. Ann Rheum Dis 2003; 
62: 1178–1184.
Lee RK, Chan CC. Factors effecting vocational outcomes of people 6. 
with chronic illness participating in a supported competitive open 
employment program in Hong Kong. Work 2005; 25: 359–368.
Orbon K, Schermer TR, van der Gulden JW, Chavannes NH, Akker-7. 
mans RP, Schayck OP, et al. Employment status and quality of life 
in patients with chronic obstructive pulmonary disease (COPD). 
Int Arch Occup Environ Health 2005; 78: 467–474.
Giaquinto S, Ring H. Return to work in selected disabilities. Disabil 8. 
Rehabil 2007; 29: 1313–1316.
Fowler Jr WM, Abresch RT, Koch TR, Brewer ML, Bowden RK, 9. 
Wanlass RL. Employment profiles in neuromuscular diseases. Am 
J Phys Med Rehabil 1997; 76: 26–37.
Kalkman JS, Schillings ML, Werf SP, Padberg GW, Zwarts MJ, 10. 
van Engelen BG. Experienced fatigue in Facioscapulohumeral 
Dystrophy, Myotonic Dystrophy and HMSN –I patients. J Neurol 
Neurosurg Psychiatry 2005; 76: 1406–1409.
Minis MAH, Heerkens YF, Engels JA, van Engelen BGM, Oosten-11. 
dorp RAB. Classification of employment factors according to the 
International Classification of Functioning, Disability and Health 
(ICF) in patients with neuromuscular diseases: A systematic review. 
Disabil Rehabil 2009; 31: 2150–2163.
Ybema JF, Evers M. [Quality of life. Profile Labour and Health]. 12. 
Hoofddorp: TNO [Dutch Organization for Scientific Research]; 
2005 (in Dutch). 
Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer 13. 
JW, Bleijenberg G. Dimensional assessment of chronic fatigue 
syndrome J Psychosom Res 1994; 38: 383–392.
Vercoulen JH, Alberts M, Bleijenberg G. [The Checklist Individual 14. 
Strength (CIS)]. Gedragstherapie 1999; 32׃ 131–136 (in Dutch).
Bültmann U, Kant I, Kaal SV, Beurskens AJ, van den Brandt PA. 15. 
Fatigue and psychological distress in the working population: 
psychometrics, prevalence and correlates. J Psychosom Res 2002; 
52: 445–452.
Beurskens AJ, Bültmann U, Kant I, Vercoulen JH, Bleijenberg G, 16. 
Swaen GM. Fatigue among working people: validity of a question-
naire measure. Occup Environ Med 2000; 57: 353–357.
Dittner AJ, Wesseley SC, Brown RG. The assessment of fatigue: 17. 
a practical guide for clinicians and researchers. J Psychosom Res 
2004; 56: 157–170.
Aaronson NK, Mulder M, Cohen PD, Essink-Bot ML, Fekkes M, 18. 
Sanderman R, et al. Translation, validation and norming of the Dutch 
Language version of the SF-36 Health Survey in community and 
chronic disease population, J Clin Epidemiol 1998; 51: 1055–1068.
Andries F, Wevers CWJ, Wintzen AR, Busch HF, Howeler CJ, 19. 
de Jager AE, et al. Vocational perspectives and neuromuscular 
diseases. Int J Rehabil Res 1997; 20: 255–273.
Andries F. [Followed at a distance, research into labour in the 20. 
lives of patients with a neuromuscular disease]. Hoofddorp: TNO; 
2000 (in Dutch).
Harper PS. Myotonic dystrophy, 3rd edition. London: WB Saun-21. 
ders; 2001.
Abresch RT, Carter GT, Jensen MP, Kilmer DD. Assessment of pain 22. 
and health-related quality of life in slowly progressive neuromus-
cular disease. Am J Hosp Palliat Care 2002; 19: 39–48.
Jensen MP, Abresch RT, Carter GT, McDonald CM. Chronic pain 23. 
in persons with neuromuscular disease. Arch Phys Med Rehabil 
2005; 86: 1155–1163.
Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, 24. 
McDonald CM. Chronic pain in persons with myotonic dystrophy 
and fascioscapulohumeral dystrophy. Arch Phys Med Rehabil 
2008; 89: 320–328.
Wokke HJ. Fatigue is part of the burden of neuromuscular diseases. 25. 
J Neurol 2007; 254: 948–949.
Féasson L, Camdessanché JP, El Mandhi L, Calmels P, Millet 26. 
GY. Fatigue and neuromuscular diseases. Ann Readapt Med Phys 
2006; 49: 289–300.
Schillings ML, Kalkman JS, Janssen HM, van Engelen BG, Blei-27. 
jenberg G, Zwarts MJ. Experienced and physiological fatigue in 
neuromuscular disorders. Clin Neurophysiol 2007; 118: 292–300.
Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijen-28. 
berg G. The development of a model of fatigue in neuromuscular dis-
orders: a longitudinal study. J Psychosom Res 2007; 62: 571–579.
Boström K, Ahlström G. Quality of life in patients with muscu-29. 
lar dystrophy and their next of kin. Int J Rehabil Res 2005; 28: 
103–109.
Natterlünd B, Ahlström G. Problem-focused coping and satisfaction 30. 
with activities of daily living in individuals with muscular dystrophy 
and postpolio syndrome. Scand J Caring Sci 1999b; 13: 26–32.
Ville I, Ravaud JF, Marchal F, Paicheler H, Fardeau M. Social 31. 
identity and the International Classification of Handicaps: an 
evaluation of the consequences of facioscapulohumeral muscular 
dystrophy. Disabil Rehabil 1992; 14: 168–175.
Cardol C, de Jong BA, van den Bos GAM, Beelen A, de Groot 32. 
IJM, de Haan RJ. Beyond disability: perceived participation in 
people with a chronic disabling condition. Clin Rehabilitation 
2002; 16: 27–35.
Tschernetzki-Neilson PJ, Brintnell ES, Haws C, Graham K. 33. 
Changing to an outcome-focused program improves return to work 
outcomes. J Occup Rehabil 2007; 17: 473–486.
Wasiak R, Young AE, Roessler RT, McPherson KM, van Poppel 34. 
MNM, Anema JR. Measuring return to work. J Occup Rehabil 
2007; 17: 766–781.
J Rehabil Med 42
